| World malaria report 2023 World Health Organization World Health Organization, 2023 | 38533* | 2023 |
| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 1044 | 2021 |
| Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study TM Walker, CLC Ip, RH Harrell, JT Evans, G Kapatai, MJ Dedicoat, ... The Lancet infectious diseases 13 (2), 137-146, 2013 | 988 | 2013 |
| Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ... The Lancet infectious diseases 15 (10), 1193-1202, 2015 | 641 | 2015 |
| Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis P Bradley, NC Gordon, TM Walker, L Dunn, S Heys, B Huang, S Earle, ... Nature communications 6 (1), 10063, 2015 | 619 | 2015 |
| Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples AA Votintseva, P Bradley, L Pankhurst, C del Ojo Elias, M Loose, ... Journal of clinical microbiology 55 (5), 1285-1298, 2017 | 385 | 2017 |
| Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study LJ Pankhurst, C del Ojo Elias, AA Votintseva, TM Walker, K Cole, J Davies, ... The Lancet Respiratory Medicine 4 (1), 49-58, 2016 | 384* | 2016 |
| Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues CJ Meehan, GA Goig, TA Kohl, L Verboven, A Dippenaar, M Ezewudo, ... NATURE reviews microbiology 17 (9), 533-545, 2019 | 368 | 2019 |
| Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 341 | 2018 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 319 | 2020 |
| Identifying lineage effects when controlling for population structure improves power in bacterial association studies SG Earle, CH Wu, J Charlesworth, N Stoesser, NC Gordon, TM Walker, ... Nature microbiology 1 (5), 1-8, 2016 | 293 | 2016 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 283 | 2020 |
| Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study TM Walker, MK Lalor, A Broda, LS Ortega, M Morgan, L Parker, ... The Lancet Respiratory Medicine 2 (4), 285-292, 2014 | 250 | 2014 |
| The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 177 | 2022 |
| The duration, dynamics, and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers SF Lumley, J Wei, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... Clinical Infectious Diseases 73 (3), e699-e709, 2021 | 170 | 2021 |
| A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study TM Walker, M Merker, AM Knoblauch, P Helbling, OD Schoch, ... The Lancet Infectious Diseases 18 (4), 431-440, 2018 | 159 | 2018 |
| Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status DW Eyre, SF Lumley, J Wei, S Cox, T James, A Justice, G Jesuthasan, ... Clinical Microbiology and Infection 27 (10), 1516. e7-1516. e14, 2021 | 147 | 2021 |
| The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers SF Lumley, J Wei, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... MedRxiv, 2020.11. 02.20224824, 2020 | 146 | 2020 |
| Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe M Hunt, P Bradley, SG Lapierre, S Heys, M Thomsit, MB Hall, KM Malone, ... Wellcome open research 4, 2019 | 140 | 2019 |
| Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data Y Yang, KE Niehaus, TM Walker, Z Iqbal, AS Walker, DJ Wilson, TEA Peto, ... Bioinformatics 34 (10), 1666-1671, 2018 | 131 | 2018 |
